Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

DENTSPLY Sirona (XRAY) stock in plain English

Free brief · no signupStart here
XRAYPublished Nov 19, 2026
DENTSPLY Sirona Inc
Healthcare · Medical Instruments & Supplies
Produces digital imaging systems, treatment chairs, and restoration equipment for clinical practices.
Assets:
Global manufacturingOperates production plants across North America, Europe, and Asia
15,000 employeesMaintains workforce dedicated to dental equipment engineering and clinical support
Consumable product linesProduces endodontic instruments, preventive pastes, and restorative materials
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

35
OPS ScoreOperating finances
Latest quote
-0.35%$8.49
$1.68B
n/a (loss)
$3.58B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 19, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was XRAY. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does DENTSPLY Sirona (XRAY) do?

DENTSPLY Sirona Inc (XRAY) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Produces digital imaging systems, treatment chairs, and restoration equipment for clinical practices. Manufactures consumable dental products and equipment used by dentists and laboratories worldwide. It is worth $1.68B on the market and sold $3.58B over the last year.

Market cap
$1.68B
P/E ratio
None (reported a loss)
Annual sales
$3.58B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 19, 2026

Brands and businesses behind XRAY

  • CEREC: Chairside dental CAD and CAM systems sold to clinics for same-day crowns and restorations.
  • SureSmile: Clear aligner system providing custom orthodontic treatment plans sold directly to dental practices.
  • Astra Tech Implant System: Dental implant line generating revenue through surgical fixtures, abutments, and restorative components.
  • Cavitron: Ultrasonic scaling equipment and insert tips used by hygienists for routine teeth cleanings.
  • WaveOne: Reciprocating endodontic file system sold to specialists for root canal procedures.
  • Nupro: Prophylaxis pastes and fluoride varnishes purchased regularly by clinics for patient preventive care.

XRAY’s flags, in plain English

Each flag is a number from DENTSPLY Sirona’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.

Stupid Cash

Can pay this year's bills 1.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Wide Gross Margin

Gross margin of 50.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Cheap on Cash Flow

Priced at 16.3 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Debt Is Driving

Heavy debt, 169% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.

2 more risk notes open with the free trial. Try it free for 7 days.

Questions about XRAY

How big is DENTSPLY Sirona?

DENTSPLY Sirona’s market cap is $1.68B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.58B: what customers paid the company over the last year, before any costs.

What is XRAY’s P/E ratio?

XRAY has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with XRAY?

A large portion of elective dental treatments depends on out-of-pocket consumer spending, which softens during broader economic slowdowns. That is one risk on DENTSPLY Sirona’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From DENTSPLY Sirona’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. XRAY’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card